<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna stock (NASDAQ: MRNA) declined by about 20% over the last week (five trading days) considerably underperforming the broader S&P 500 which was down by about 3% over the same period. There are a couple of recent developments that have hurt Moderna and Covid-19 vaccine stocks in general.
...read full article on Forbes
